LOXL1 and neoplasm: Remarkably, cancer-associated fibroblast and endothelial cells, which have been reported to promote tumor progression (Chen and Song 2019; Yang et al. 2021), exhibited strong positive correlations with LOXL1 expression in the majority of cancers (Fig. 7D), indicating the immune-regulatory role of LOXL1 in cancers.